Based on the key indicators related to Oric Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Oric Pharmaceuticals is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. At present, Oric Pharmaceuticals' Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Property Plant And Equipment Net is expected to grow to about 4.3 M, whereas Total Current Liabilities is forecasted to decline to about 13.1 M. Key indicators impacting Oric Pharmaceuticals' financial strength include:
The essential information of the day-to-day investment outlook for Oric Pharmaceuticals includes many different criteria found on its balance sheet. An individual investor should monitor Oric Pharmaceuticals' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Oric Pharmaceuticals.
Please note, the presentation of Oric Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Oric Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Oric Pharmaceuticals' management manipulating its earnings.
Oric Pharmaceuticals Stock Summary
Oric Pharmaceuticals competes with Seer, Anebulo Pharmaceuticals, Cullinan Oncology, C4 Therapeutics, and Molecular Partners. ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. The company was incorporated in 2014 and is headquartered in South San Francisco, California. Oric Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 83 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Oric Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Oric Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oric Pharmaceuticals competition to find correlations between indicators driving Oric Pharmaceuticals's intrinsic value. More Info.
Oric Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Oric Pharmaceuticals' Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oric Pharmaceuticals' earnings, one of the primary drivers of an investment's value.
Oric Pharmaceuticals Systematic Risk
Oric Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Oric Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was seven with a total number of output elements of fifty-four. The Beta measures systematic risk based on how returns on Oric Pharmaceuticals correlated with the market. If Beta is less than 0 Oric Pharmaceuticals generally moves in the opposite direction as compared to the market. If Oric Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Oric Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Oric Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Oric Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Oric Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Oric Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Oric Pharmaceuticals growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.7
At present, Oric Pharmaceuticals' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.
Oric Pharmaceuticals April 2, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Oric Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oric Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oric Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Oric Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oric Pharmaceuticals's daily price indicators and compare them against related drivers.
When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.